<DOC>
	<DOC>NCT01408082</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical efficacy and safety of ISV-502 compared to AzaSiteÂ® alone, Dexamethasone alone, and vehicle in the treatment of subjects with Non-bacterial Blepharitis.</brief_summary>
	<brief_title>Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Are at least 18 years of age at Visit 1 (Day 1, Baseline) of either sex and any race. Signature of the subject or legally authorized representative on the Informed Consent Form. Are willing and able to follow all instructions and attend all study visits. Are willing to avoid disallowed medication for the duration of the study. If female is of childbearing potential, agree to and submit a urine sample for pregnancy testing. Post menopausal is defined as having no menses for at least 12 consecutive months. Additional inclusion criteria also apply. Have known sensitivity or poor tolerance to any component of the Investigational Drug. Have an acute ocular infection (bacterial, viral or fungal) or active ocular inflammation other than Blepharitis in the study eye. Have used topical corticosteroid medications or topical ophthalmic solutions that the investigator feels may interfere with the study parameters. Have used any nondiagnostic topical ophthalmic solutions in the study eye. Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive urine pregnancy test. Currently suffer from alcohol and/or drug abuse. Have prior (within 30 days of beginning dosing) or anticipated concurrent use of an investigational drug or device. Have a condition or a situation which, in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation. Additional exclusion criteria also apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>